TickerFactsScreenerDevelopers

Viridian Therapeutics, Inc.\DE (VRDN) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2013: -$23.89M2014: $5.99M2015: -$45.29M2016: -$61.92M2017: $38.51M2018: $51.34M2019: $15.75M2020: $120.04M2021: $187.72M2022: $395.06M2023: $442.02M2024: $671.64M2025: $722.17M$722.17M
2013Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$722.17M+7.5%
2024$671.64M+51.9%
2023$442.02M+11.9%
2022$395.06M+110.5%
2021$187.72M+56.4%
2020$120.04M+661.9%
2019$15.75M-69.3%
2018$51.34M+33.3%
2017$38.51M+162.2%
2016-$61.92M-36.7%
2015-$45.29M-856.0%
2014$5.99M+125.1%
2013-$23.89M—